Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02801
Species: Homo sapiens
Position : chr10:51546800-51547317
Year: 2016
Title: Chromatin interactions and candidate genes at ten prostate cancer risk loci.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  26979803
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: DU145
CVCL ID: CVCL_0105
Experiment Type: Enhancer activity assay; Chromatin interaction assay; TF binding assay; Disease-variant functional analysis
High Throughput Method: Capture 3C-seq; ChIP-seq; RNA-seq; SNP genotyping array; eQTL analysis; GWAS
Low Throughput Method: Luciferase reporter assay; Site-directed mutagenesis; 3C-qPCR; RT-qPCR; 3C
About Target Gene
Target gene : NA
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19) 15 found
Enhancer ID Position Tissue Cell Disease
E_02744 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02745 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02746 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02747 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02748 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02749 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02750 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02751 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02800 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02802 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02803 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02821 chr10:51546800-51547317 prostate gland NA NA
E_02822 chr10:51546800-51547317 prostate gland NA NA
E_02823 chr10:51546800-51547317 prostate gland NA NA
E_02824 chr10:51546800-51547317 prostate gland NA NA
Expression of Target Genes for the Enhancer